DUBLIN, April 4, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/klwr9r/global_stem_cell) has announced the addition of the "Global Stem Cell Anticancer Therapeutics Market" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market.
The report, the Global Stem Anticancer Therapeutics Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Stem Anticancer Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
One of the main trends witnessed in the Global Stem Cell Anticancer Therapeutics market is the increase in industry activities. Cancer therapy apart from usual radiotherapy has entered into new era of stem cell therapy. Research is going on to recognize and isolate cancer stem cells with those of normal stem cells by using cell surface antigen markers.
More intricate research work is needed to carry out reveal signalling pathways and functioning of different genes in process of carcinogenesis during cancer stem cell differentiation. This would help in development of new therapies which would help in elimination of eventual disease and recurrence. This trend is expected to have a strong impact on the growth of the market.
According to the report, one of the main factors driving the market is the significant increase in the drug pipeline targeting cancer stem cells. These cells have the capacity to divide and give rise to new cancer stem cells through a process called self-renewal and have the ability to change into the other cells that form the bulk of the tumour.
Further, the report states that one of the main challenges is the lack of awareness in developing countries. Most of the patients in developing countries such as India and China are not fully aware of the recent developments in stem cell products and therapies.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Curis Inc., Exelixis Inc., Gamida Cell Ltd., Lonza Group, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Verastem Inc.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Key Topics Covered:
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
5. Scope of the Report
6. Stem Cells
7. Market Landscape
8. Geographical Segmentation
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
17. Other Reports in this Series
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/klwr9r/global_stem_cell
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article